As of 2025-07-07, the EV/EBITDA ratio of KemPharm Inc (KMPH) is -6.44. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. KMPH's latest enterprise value is 153.95 mil USD. KMPH's TTM EBITDA according to its financial statements is -23.90 mil USD. Dividing these 2 quantities gives us the above KMPH EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.1x - 10.3x | 8.1x |
| Forward P/E multiples | 11.1x - 17.7x | 14.8x |
| Fair Price | (6.35) - (5.77) | (6.58) |
| Upside | -209.4% - -199.3% | -213.3% |
| Date | EV/EBITDA |